European medical device firm signs multiyear agreement to use OmniComm’s TrialMaster EDC for ophthalmological research
A major European medical device company specializing in ophthalmology has signed a three-year agreement to use TrialMaster EDC…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Mar 19
A major European medical device company specializing in ophthalmology has signed a three-year agreement to use TrialMaster EDC…
08 Mar 19
LumiThera Inc., a commercial-stage medical device company focused on developing photobiomodulation (PBM) therapies for ocular disorders and diseases,…
26 Feb 19
Global eye health firm Bausch + Lomb has secured approval from the US Food and Drug Administration (FDA)…
21 Feb 19
UK-based ReNeuron said that its its human retinal progenitor cells (hRPC) cell therapy candidate has demonstrated significant restoration…
21 Feb 19
Ocular Therapeutix has dosed the first patient in a phase 1 trial of tyrosine kinase inhibitor implant (OTX-TKI)…
20 Feb 19
Alcon, the global leader in eye care and a division of Novartis, will debut the iLux MGD treatment…
28 Jan 19
Bruder Healthcare has announced the immediate availability of Eyeleve, the first and only compress clinically proven to increase…
25 Jan 19
Tangible Science, LLC, an innovator creating a dramatically better contact lens experience for patients and eye care practices,…
17 Jan 19
Moves to make hospital-grade technologies available for detecting early signs of vision-threatening eye diseases such as Glaucoma in…
11 Jan 19
Medical device firm SightGlass Vision has started enrolling children aged between six and nine years at its multicenter…